Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: a population pharmacokinetic approach-Reference-Cited by-同舟云学术

Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: a population pharmacokinetic approach

Published:2019-02-04 Issue: Volume: Page:
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Tang Dan¹²³,Song Bai‐Li³⁴,Yan Miao¹²,Zou Jian‐Jun³⁴,Zhang Min⁵,Zhou Hua‐Ying⁵,Wang Feng¹²,Xiao Yi‐Wen¹²,Xu Ping¹²,Zhang Bi‐Kui¹²,Chen Xi‐Jing³,Xiang Da‐Xiong¹²,Banh Hoan Linh⁶

Affiliation:

1. Department of Pharmacy the Second Xiangya Hospital Central South University Changsha Hunan 410011China

2. Institute of Clinical Pharmacy Central South University Changsha Hunan 410011China

3. School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing Jiangsu 211100China

4. Department of Clinical Pharmacology Nanjing First Hospital Nanjing Medical University NanjingJiangsu 210006China

5. Department of Infectious Diseases the Second Xiangya Hospital Central South University Changsha Hunan 410011China

6. Department of Family Medicine Faculty of Medicine and Dentistry University of Alberta Edmonton AB Canada

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13208

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis;Frontiers in Pharmacology;2024-08-20

2. Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients;Pharmaceuticals;2024-05-22

3. Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial;Trials;2023-12-17

4. The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals;Frontiers in Genetics;2023-08-24

5. Optimization of Voriconazole Dosing Regimens Against Aspergillus Species and Candida Species in Pediatric Patients After Hematopoietic Cell Transplantation: A Theoretical Study Based on Pharmacokinetic/Pharmacodynamic Analysis;The Journal of Clinical Pharmacology;2023-05-11